Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | EYA2 | O00167 | 1/20 | 0.65 |
| ▸ | APP | P05067 | 1/20 | 0.65 |
| ▸ | ACE | P12821 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 2/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.62 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | DRD1 | P21728 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
| ▸ | DRD3 | P35462 | 1/20 | 0.62 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.62 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8625926 | 0.91 | TDP1 (0.54) | TDP1EYA2APPACEBLM | |
| SCHEMBL20183298 | 0.89 | TDP1 (0.52) | TDP1EYA2APPACEBLM | |
| SCHEMBL10385583 | 0.89 | TDP1 (0.52) | TDP1EYA2APPACEBLM | |
| SCHEMBL111010 | 0.88 | TDP1 (0.56) | TDP1EYA2APPACEBLM | |
| SCHEMBL9714346 | 0.87 | TDP1 (0.50) | TDP1EYA2APPACEBLM | |
| SCHEMBL8968772 | 0.87 | TDP1 (0.50) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1077971 | 0.86 | TDP1 (0.61) | TDP1EYA2APPACEBLM | |
| SCHEMBL11797447 | 0.86 | TDP1 (0.54) | TDP1EYA2APPACEBLM | |
| SCHEMBL18793625 | 0.86 | TDP1 (0.54) | TDP1EYA2APPACEBLM | |
| SCHEMBL18335460 | 0.85 | TDP1 (0.48) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270184-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2025-08-28 | — | — | US | claimed |
| CN-120121830-A | Agkistrodon acutus venom detection kit and detection method thereof | 广西医科大学第一附属医院 | 2025-06-10 | — | — | CN | claimed |
| CN-120121831-A | High-sensitivity detection method and kit for urine soluble CD163 | 浙江理工大学 | 2025-06-10 | — | — | CN | claimed |
| EP-4522619-A1 | PROCESS FOR PREPARING ZANUBRUTINIB IN AMORPHOUS FORM | OLON S.p.A. (IT) | 2025-03-19 | — | — | EP | claimed |
| EP-4511365-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | Teva Pharmaceuticals International GmbH (CH) | 2025-02-26 | — | — | EP | claimed |
| EP-4479546-A2 | PROCESSES FOR PREPARATION OF AVACOPAN AND INTERMEDIATES THEREOF | Teva Pharmaceuticals International GmbH (CH) | 2024-12-25 | — | — | EP | claimed |
| CN-118878768-A | Thienyl COF material, synthesis method thereof and iodine adsorption application | 陕西科技大学 | 2024-11-01 | — | — | CN | claimed |
| CN-118878538-A | Novel preparation method of green lumepiquat chloride | 江苏宝东医药科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| WO-2024224426-A1 | PROCESS FOR THE PREPARATION OF 7-CHLORO-6-FLUORO-(1M)-1-[4-METHYL-2-(PROPAN-2-YL)PYRIDIN-3-YL]PYRIDO[2,3-D] PYRIMIDINE-2,4(1H,3H)-DIONE (M-DIONE) | NATCO PHARMA LIMITED (IN) | 2024-10-31 | — | — | WO | claimed |
| EP-4063433-B1 | HYDROGEL OF MERCAPTO-MODIFIED MACROMOLECULAR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | BLAFAR BIOTECHNOLOGY HANGZHOU LTD (CN) | 2024-09-04 | — | — | EP | claimed |
| WO-2022252012-A1 | TUMOR DIAGNOSIS AND TREATMENT AGENT, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 深圳先进技术研究院 | 2022-12-08 | — | — | WO | claimed |
| CN-115144585-A | ST2 detection method based on magnetic particle time-resolved fluoroimmunoassay | 浙江理工大学 | 2022-10-04 | — | — | CN | claimed |
| EP-4063433-A1 | HYDROGEL OF MERCAPTO-MODIFIED MACROMOLECULAR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Blafar Biotechnology (Hangzhou) Ltd. (CN) | 2022-09-28 | — | — | EP | claimed |
| CN-115078708-A | Pancreatic stone protein detection method based on magnetic particle time-resolved fluorescence immunoassay | 浙江理工大学 | 2022-09-20 | — | — | CN | claimed |
| CN-114717036-A | Preparation method of ashless dispersant | 中国石油天然气股份有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-113717176-B | Method for preparing remazolam | 上海再启生物技术有限公司 | 2022-07-05 | — | — | CN | claimed |
| CN-110981901-B | Purification method of amino-terminated siloxane | 上海彩迩文生化科技有限公司 | 2022-07-05 | — | — | CN | claimed |
| CN-114686019-A | Improved production process of PR122 | 浙江永泉化学有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114314560-A | Preparation method of gadolinium-doped mesoporous carbon sphere nanoparticles | 徐州医科大学 | 2022-04-12 | — | — | CN | claimed |
| US-11279685-B2 | Enantiomeric separation of racemic nicotine by addition of an O,O″-disubstituted tartaric acid enantiomer | SIEGFRIED AG (CH) | 2022-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11279685-B2 | Enantiomeric separation of racemic nicotine by addition of an O,O″-disubstituted tartaric acid enantiomer | CHRNB1, CHRNA1, CHRM1 | TDP1 316/4885EYA2 3631/4885APP 2589/4885 |
| US-20250270184-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | CYP11B1, CYP11B2, HSD17B7 | TDP1 1814/4885EYA2 1336/4885APP 2683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.